# Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A)

**Authors:** Katarzyna Stawarz, Monika Durzynska, Adam Galazka, Monika Paszkowska, Karolina Bienkowska-Pluta, Jakub Zwolinski, Andrzej Tysarowski, Ewa Kwiatkowska, Agnieszka Podgorska

PMC · DOI: 10.1186/s12957-024-03418-1 · World Journal of Surgical Oncology · 2024-05-27

## TL;DR

Two sisters were diagnosed with two rare genetic disorders, MEN2A and FPGL1, highlighting the importance of genetic testing in complex cases.

## Contribution

This is the first report of two related patients with co-occurring RET and SDHD mutations causing distinct hereditary syndromes.

## Key findings

- Both sisters had a RET gene mutation (p.Val804Met) and an SDHD gene variant (p.Arg22Ter).
- The combination of MEN2A and FPGL1 in related individuals is a novel clinical observation.
- Thyroidectomy was performed following diagnosis to manage the syndromes.

## Abstract

In clinical practice, genetic testing has become standard for many cancerous diseases. While a diagnosis of a single hereditary syndrome is not uncommon, the coexistence of two genetic diseases, even with partially common symptoms, remains unusual. Therefore, targeted next-generation sequencing (NGS), along with genetic consultation and imaging studies, is essential for every patient with confirmed paraganglioma. In this report, we present two sisters diagnosed with multiple endocrine neoplasia type 2 (MEN2A) and familial paraganglioma syndrome type 1 (FPGL1).

After presenting to the clinic with neck tumors persisting for several months, both patients underwent tumor removal procedures following imaging and laboratory studies. Pathological reports confirmed the diagnosis of paragangliomas. Subsequently, genetic testing, including NGS, revealed a mutation in the rearranged during transfection (RET) gene: the heterozygous change (c.2410G > A), (p.Val804Met), and a variant of the succinate dehydrogenase complex subunit D (SDHD) gene: (c.64 C > T), (p.Arg22Ter). Subsequently, thyroidectomy procedures were scheduled in both cases.

To the best of our knowledge, this is the first report presenting these two mutations in two related patients, resulting in distinctive genetic syndromes with similar manifestations. This underscores that although infrequent, multiple hereditary disorders may co-occur in the same individual.

## Linked entities

- **Genes:** RET (ret proto-oncogene) [NCBI Gene 5979], SDHD (succinate dehydrogenase complex subunit D) [NCBI Gene 6392]

## Full-text entities

- **Genes:** SDHD (succinate dehydrogenase complex subunit D) [NCBI Gene 6392] {aka CBT1, CII-4, CWS3, MC2DN3, PGL, PGL1}
- **Diseases:** genetic diseases (MESH:D030342), cancerous diseases (MESH:D009369), familial paraganglioma syndrome type 1 (MESH:D010235), neck tumors (MESH:D006258), hereditary disorders (MESH:D009386), MEN2A (MESH:D018813)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Arg22Ter, p.Val804Met, c.2410G > A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11129478/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11129478/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11129478/full.md

---
Source: https://tomesphere.com/paper/PMC11129478